Ignite Creation Date:
2024-05-06 @ 7:15 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05943977
Status:
COMPLETED
Last Update Posted:
2024-01-02
First Post:
2023-03-22
Brief Title:
A Bioequivalence and Efficacy Study of MB-102 Relmapirazin in Chinese Participants
Sponsor:
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Organization:
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-03-22
First Submit QC Date:
July 11 2023
Study First Post Date:
2023-07-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-28
Last Update Post Date:
2024-01-02
Last Update Post Date Type:
ACTUAL